RecruitingNCT05307003

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Trazodone vs. Quetiapine for the Treatment of ICU Delirium: A Prospective Observational Pilot Study


Sponsor

University of Southern California

Enrollment

60 participants

Start Date

Apr 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a single-center, prospective observational pilot study. The objective of this study is to evaluate the effectiveness of trazodone as compared to quetiapine, in the management of ICU delirium in adult (\>=18 years old) surgical and medical ICU patients. The investigators will compare outcomes such as delirium duration, delirium-free days, coma-free days, in-hospital mortality, 28-day mortality, hospital length of stay (LOS), ICU LOS, mechanical ventilator days, complications, adverse effects, rescue medication use, delirium symptom severity, sleep duration, and sleep quality among participants receiving trazodone or quetiapine. The investigators hypothesize participants receiving trazodone will be associated with a shorter duration of delirium, decreased delirium severity, and improved sleep quality compared to participants receiving quetiapine.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares trazodone versus quetiapine for treating ICU delirium - confusion and agitation that can affect patients in the intensive care unit. The study looks at which medication works better at calming symptoms, improving sleep, and reducing dangerous behaviors in critically ill patients. You may be eligible if: - You are 18 or older - You have been admitted to the surgical ICU for more than 24 hours - You have been diagnosed with delirium (confirmed by CAM-ICU assessment) with disruptive symptoms requiring medication - You are receiving either trazodone or quetiapine for delirium You may NOT be eligible if: - You were admitted with an acute neurological condition (stroke, brain injury, brain tumor) - You are pregnant or breastfeeding - You have a history of dangerous heart rhythms (torsade de pointes, heart block) - You have dementia, Parkinson's disease, schizophrenia, or another psychotic disorder - You cannot speak or understand English - You are expected to die or be transferred out of the ICU within 24 hours - You have a prolonged QT interval on ECG or a seizure disorder - You recently had a heart attack (within 30 days) - You are in alcohol or substance withdrawal - You have liver disease or symptomatic low sodium Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTrazodone

Medication used to treat ICU delirium

DRUGQuetiapine

Medication used to treat ICU delirium


Locations(1)

Keck Hospital of the University of Southern California

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05307003


Related Trials